propose

# Systematic Evaluation of Closed-Loop tFUS Targeting SST Interneurons for Gamma Restoration in AD

## Mechanistic Rationale Analysis

### 1. Foundational Circuit Logic

The hypothesis presents a coherent circuit mechanism with the following logical structure:

**Pathogenic cascade:**
- Aβ preferentially targets PV+ interneurons (well-documented)
- Loss of PV inhibition → disinhibition of excitatory networks → hyperexcitability
- Compensatory SST interneuron hyperactivity emerges as homeostatic response
- Excess SST output creates dual inhibition on: (a) pyramidal cell dendrites, (b) surviving PV interneurons
- This creates a **vicious cycle** where remaining PV cells cannot generate gamma

**Therapeutic logic:**
- Reducing SST activity → removes inhibition from PV cells ("disinhibition")
- PV disinhibition → restores gamma generation capability
- Restored gamma → improves memory encoding and potentially clears Aβ

The mechanistic rationale is **plausible but requires qualification**. The concept of "indirect disinhibition" through SST modulation is consistent with known hippocampal microcircuitry—the SST+ O-LM interneurons do form inhibitory synapses onto PV+ basket cells in the stratum oriens-alveus border (J. physiol. 2018; 596:3745). However, the directionality of the proposed modulation (inhibition of SST neurons, not excitation) distinguishes this from standard disinhibition architectures and represents a novel therapeutic angle.

### 2. Gene/Target Validity: SST

**Evidence supporting SST as disease-relevant:**

| Finding | Source/Context |
|---------|----------------|
| SST expression declines with AD progression | Human postmortem hippocampal tissue (AD cases show 30-50%